Blog

Charlie Garnett-Benson: New open roles on our Translational Development teams

Charlie Garnett-Benson/LinkedIn

Mar 14, 2025, 13:00

Charlie Garnett-Benson: New open roles on our Translational Development teams

Charlie Garnett-Benson, Executive Director-Translation Medicine Development Portfolio Team Lead at Bristol Myers Squibb, shared a post on LinkedIn:

“Sharing some new open roles on our Translational Development teams.

Feel free to apply if you have an interest in transforming patients lives through science with us.

Senior Principal Scientist, Translational Development, Pancreatic Cancer Disease Lead.
Senior Principal Scientist/Associate Director, Translational Development, Lung Cancer Disease Lead.
Principal Scientist, Translational Development, Breast Cancer Disease Lead.“

Breast Cancer Bristol Myers Squibb cancer Charlie Garnett-Benson fight against cancer Global fight against cancer Lung cancer OncoDaily Oncology Pancreatic Cancer

New Paper Alert: Management of Immune Checkpoint Inhibitor-Associated Toxicities in Older Adults with Cancer

Kimryn Rathmell was Awarded 2025 ACS Medal of Honor

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

Special Coverage